Solvay Pharma India Ltd(merged)
In the Dec 2025 quarter, revenue rose 26.3% year on year to ₹10.53 Cr and net profit was ₹0.54 Cr, against −₹2.65 Cr a year earlier (compared with Dec 2024). Promoters held 63.96% of Solvay Pharma India Ltd(merged) in Dec 2025, unchanged from Sep 2025.
Peer Comparison
Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
| ₹1,764.30 | 35.00 | 4,23,315 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,625.50 | 87.36 | 2,55,527 Cr | 15.25 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,588.10 | 72.03 | 1,74,517 Cr | 9.50 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,185.00 | 107.95 | 1,18,058 Cr | 22.28 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,182.10 | 26.30 | 1,17,915 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,346.40 | 34.87 | 1,12,381 Cr | 2.90 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,370.40 | 32.83 | 1,10,709 Cr | 3.13 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
Solvay Pharma India Ltd(merged) (this company) | — | — | — | — | — | — | — | 43 Cr | 3 Cr |
| Median 8 companies | ₹1,764.30 | 35.00 | 1,18,058 Cr | 5.07 | 0.61% | 13.79% | 17.94% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
5- Company is almost debt free.
- Company has delivered good profit growth of 22.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
- Company has been maintaining a healthy dividend payout of 31.1%
- Debtor days have improved from 25.1 to 18.6 days.
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.83 | 11.88 | 30.66 | 16.09 | 11.5 | 5.51 | 15.59 | 10.22 | 8.34 | 8.04 | 16.44 | 8.92 | 10.53 |
| Expenses | 23.73 | 19.16 | 25.42 | 15.54 | 14 | 9.04 | 14.21 | 13.06 | 11.49 | 14.84 | 16.31 | 10.18 | 10.51 |
| Operating Profit | -3.9 | -7.28 | 5.24 | 0.55 | -2.5 | -3.53 | 1.38 | -2.84 | -3.15 | -6.8 | 0.13 | -1.26 | 0.02 |
| OPM % | -19.67% | -61.28% | 17.09% | 3.42% | -21.74% | -64.07% | 8.85% | -27.79% | -37.77% | -84.58% | 0.79% | -14.13% | 0.19% |
| Other Income | 0.75 | 4.3 | 0.72 | 3.01 | 3.5 | 0.98 | 1.61 | 2.3 | 1.05 | 4.99 | 2.2 | -0.68 | 0.54 |
| Interest | 0.01 | 0.44 | 0.13 | 0.08 | 0.08 | 0.25 | 0.1 | 0.09 | 0.11 | 0.26 | 0.08 | 0.11 | 0.06 |
| Depreciation | 0.42 | 0.8 | 0.48 | 0.48 | 0.52 | 0.53 | 0.5 | 0.51 | 0.45 | 0.59 | 0.44 | 0.52 | 0.06 |
| PBT | -3.58 | -4.22 | 5.35 | 3 | 0.4 | -3.33 | 2.39 | -1.14 | -2.66 | -2.66 | 1.81 | -2.57 | 0.44 |
| Tax % | -25.98% | -21.33% | 15.33% | -31% | 290% | -44.44% | 12.97% | 21.93% | 0% | -219.92% | -96.13% | 47.47% | -22.73% |
| Net Profit | -2.65 | -3.32 | 4.53 | 3.93 | -0.76 | -1.85 | 2.09 | -1.4 | -2.65 | 3.19 | 3.55 | -3.8 | 0.54 |
| EPS (₹) | -1.79 | -2.24 | 3.06 | 2.66 | -0.51 | -1.25 | 1.41 | -0.95 | -1.79 | 2.16 | 2.4 | -2.57 | 0.36 |
Profit & Loss
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 |
|---|---|---|---|---|---|---|
| Sales | 130 | 144 | 167 | 202 | 242 | 295 |
| Expenses | 99 | 113 | 123 | 156 | 183 | 222 |
| Operating Profit | 30 | 31 | 44 | 46 | 59 | 73 |
| OPM % | 23% | 21% | 26% | 23% | 24% | 25% |
| Other Income | 3 | 4 | 4 | 6 | 5 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 1 | 3 | 3 |
| PBT | 28 | 30 | 43 | 50 | 61 | 76 |
| Tax % | 36% | 37% | 34% | 35% | 34% | 33% |
| Net Profit | 18 | 19 | 28 | 33 | 40 | 51 |
| Div. Payout % | 17% | 22% | 72% | 27% | 41% | 25% |
Balance Sheet
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 |
|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 63 | 77 | 82 | 104 | 125 | 161 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 21 | 26 | 32 | 48 | 41 | 54 |
| Total Liabilities | 89 | 108 | 119 | 157 | 172 | 220 |
| Fixed Assets | 10 | 7 | 4 | 2 | 38 | 36 |
| CWIP | 0 | 0 | 0 | 35 | 0 | 0 |
| Investments | 7 | 14 | 40 | 17 | 16 | 37 |
| Other Assets | 72 | 87 | 74 | 103 | 118 | 148 |
| Total Assets | 89 | 108 | 119 | 157 | 172 | 220 |
Cash Flow
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 |
|---|---|---|---|---|---|---|
| Operating | 17 | 15 | 27 | -7 | 70 | 27 |
| Investing | -6 | -6 | -24 | 1 | -9 | -17 |
| Financing | -3 | -4 | -19 | -12 | -15 | -12 |
| Net Cash Flow | 8 | 6 | -17 | -17 | 46 | -2 |
| Free Cash Flow | 17 | 14 | 24 | -34 | 59 | 26 |
| CFO/OP | 91 | 91 | 92 | 27 | 152 | 74 |
Ratios
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 |
|---|---|---|---|---|---|---|
| Debtor Days | 36 | 36 | 36 | 33 | 24 | 19 |
| Inventory Days | 113 | 136 | 118 | 240 | 116 | 165 |
| Days Payable | 94 | 107 | 89 | 134 | 74 | 87 |
| Cash Conversion Cycle | 56 | 65 | 66 | 140 | 66 | 96 |
| Working Capital Days | 44 | 47 | 34 | 82 | 33 | 49 |
| ROCE % | — | 39% | 51% | 51% | 50% | 51% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Solvay Pharma India Ltd(merged) insights
29 extracted metrics + investor summaries across FY05–FY25.
Documents
Frequently Asked Questions about Solvay Pharma India Ltd(merged)
What does Solvay Pharma India Ltd(merged) do?
Where is Solvay Pharma India Ltd(merged) (532447) listed?
Which sector does Solvay Pharma India Ltd(merged) belong to?
Company Information
Solvay Pharma India Limited(merged), incorporated in India, listed on the Bombay Stock Exchange, the company is engaged in tablets, capsules, syrups, etc.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532447.md for Solvay Pharma India Ltd(merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.